It's a fickle industry, given the uncertainty over the Affordable Care Act and government reimbursements, but opportunities in lending to medical practices and device manufacturers make it hard to resist, bankers say.
Some executives are shrugging off recent defaults as isolated incidents, but others say states’ uneven embrace of the Affordable Care Act, as well as potential changes to the law itself, have escalated the risks in lending to health firms.
